Kyle C. Molina

913 citations
41 papers · 477 indexed · 1 hit paper · h-index 13
Topics
SARS-CoV-2 and COVID-19 Research (9 papers)COVID-19 Clinical Research Studies (9 papers)Antimicrobial Resistance in Staphylococcus (9 papers)
Journals
SHILAP Revista de lepidopterologíaClinical Infectious DiseasesAntimicrobial Agents and Chemotherapy

In The Last Decade

Kyle C. Molina

38 papers receiving 471 citations

Hit Papers

Real-world use of nirmatrelvir–ritonavir in outpatients w...20232026202420252023255075

Peers

Kyle C. Molina
Comparison fields: 5 of 72
  • Infectious Diseases 348
  • Epidemiology 163
  • Pharmacology 126
  • Clinical Biochemistry 74
  • Molecular Medicine 64
Replace Odaliz Abreu-Lanfranco with:
Odaliz Abreu-Lanfranco United States
Akari Shigemi Japan
Anupop Jitmuang Thailand
R. Brigg Turner United States
Bhagyashri Navalkele United States
Abi Jenkins United Kingdom
Brian M Hoff United States
Juan Frasquet Spain
Yong Kyun Kim South Korea
Tetsuya Horino Japan
Kyle C. Molina relative to Odaliz Abreu-Lanfranco United States Odaliz Abreu-Lanfranco's profile →
Citations per field
00.5×8.6×
Odaliz Abreu-Lanfranco · 1×
Citations per year

Countries citing papers authored by Kyle C. Molina

Since Specialization
Citations

This map shows the geographic impact of Kyle C. Molina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle C. Molina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle C. Molina more than expected).

Fields of papers citing papers by Kyle C. Molina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle C. Molina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle C. Molina. The network helps show where Kyle C. Molina may publish in the future.

Co-authorship network of co-authors of Kyle C. Molina

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle C. Molina. A scholar is included among the top collaborators of Kyle C. Molina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle C. Molina. Kyle C. Molina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 2
4 1
5 3
6 1
7 2
8 0
9 1
10 7
11 9
12
Real-world use of nirmatrelvir–ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort studybreakdown →
75
13 3
14 12
15 17
16 2
17 23
18 8
19 14
20 7

About Kyle C. Molina

Kyle C. Molina is a scholar working on Infectious Diseases, Microbiology and Clinical Biochemistry, having authored 41 papers that have together received 477 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (9 papers) and Antimicrobial Resistance in Staphylococcus (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (38 citations), Infectious Diseases (348 citations) and Molecular Medicine (64 citations). Kyle C. Molina has collaborated with scholars based in United States, Mexico and Canada. Frequent co-authors include Matthew A. Miller, Martin Kršák, Scott W. Mueller, Tyree H. Kiser, Vanthida Huang, Taylor Morrisette, Seth Russell, Nichole E. Carlson, Laurel Beaty and David Mayer. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026